Lung fuction < Lung function < Lung function abnormalities

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Lung function

Number of relevant bibliographic references: 44.
[0-20] [0 - 20][0 - 44][20-40]

Ident.	Authors (with country if any)	Title
001140 (2013)		DTB Select: 11 | November 2013
001143 (2013)	Surendran Thavagnanam [Canada, Malaisie] ; Ernest Cutz [Canada] ; David Manson [Canada] ; Lawrence M. Nogee [Canada, États-Unis] ; Sharon D. Dell [Canada]	Variable clinical outcome of ABCA3 deficiency in two siblings
001156 (2013)	C. H. To ; C. C. Mok ; H. So ; M. L. Yip ; K. Y. S. Ying [République populaire de Chine]	THU0243 Standardized mortality ratios and predictors of survival in 215 southern chinese patients with inflammatory myopathies
001514 (2011)	Hussain Parappil [Qatar] ; Ahmad Al Baridi [Qatar] ; Sajjad Ur Rahman [Qatar] ; Mahmood H. Kitchi [Qatar] ; P. Ruef [Allemagne] ; M. Griese [Allemagne] ; P. Lohse [Allemagne] ; C. Aslanidis [Allemagne] ; G. Schmitz [Allemagne] ; L. Koch [Allemagne] ; J. Poeschl [Allemagne]	Respiratory distress syndrome due to a novel homozygous ABCA3 mutation in a term neonate
001574 (2011)	Meerim Park [Corée du Sud] ; Kyung Nam Koh [Corée du Sud] ; Bo Eun Kim [Corée du Sud] ; Ho Joon Im [Corée du Sud] ; Jong Jin Seo [Corée du Sud]	Clinical features of late onset non‐infectious pulmonary complications following pediatric allogeneic hematopoietic stem cell transplantation
001583 (2011)	Juan C. Caraballo ; Cecilia Yshii ; Whitney Westphal ; Thomas Moninger [États-Unis] ; Alejandro P. Comellas [États-Unis]	Ambient particulate matter affects occludin distribution and increases alveolar transepithelial electrical conductance
001847 (2009)	Hulda Swai [Afrique du Sud] ; Boitumelo Semete [Afrique du Sud] ; Lonji Kalombo [Afrique du Sud] ; Paul Chelule [Afrique du Sud] ; Kevin Kisich [États-Unis] ; Bob Sievers [États-Unis]	Nanomedicine for respiratory diseases
001873 (2009)	Ja Reynolds [Royaume-Uni] ; V. Toescu [Royaume-Uni] ; Cs Yee [Royaume-Uni] ; A. Prabu [Royaume-Uni] ; D. Situnayake [Royaume-Uni] ; C. Gordon [Royaume-Uni]	Effects of rituximab on resistant SLE disease including lung involvement
001968 (2008)	Robert Kim [États-Unis] ; Keith C. Meyer	Review: Therapies for interstitial lung disease: past, present and future
001E27 (2005)	K. Breuer [Allemagne] ; R. Gutzmer [Allemagne] ; B. Völker [Allemagne] ; A. Kapp [Allemagne] ; T. Werfel [Allemagne]	Therapy of noninfectious granulomatous skin diseases with fumaric acid esters
001E28 (2005)	K T. M Oud [Pays-Bas] ; P. Bresser ; R J M Ten Berge [Pays-Bas] ; R E Jonkers [Pays-Bas]	The shrinking lung syndrome in systemic lupus erythematosus: improvement with corticosteroid therapy
001E57 (2005)	C. J. Corrigan ; R. J. Shiner [Royaume-Uni] ; B. H. Shakur [Royaume-Uni] ; P. W. Ind [Royaume-Uni]	Methotrexate therapy of oral corticosteroid‐dependent asthmatics reduces serum immunoglobulins: correlation with clinical response to therapy
001F57 (2004)	Eugenija Zuskin [Croatie] ; Jadranka Mustajbegovic [Croatie] ; E. Neil Schachter [États-Unis] ; Josipa Kern [Croatie] ; Vlasta Deckovic-Vukres [Croatie] ; Jasna Pucarin-Cvetkovic [Croatie] ; Iskra A. Nola-Premec [Croatie]	Respiratory findings in pharmaceutical workers
001F71 (2004)	Leland L. Fan [États-Unis] ; Robin R. Deterding [États-Unis] ; Claire Langston [États-Unis]	Pediatric interstitial lung disease revisited
002418 (2001)	Anthony J. Frew ; Martin J. Plummeridge	Alternative agents in asthma
002534 (2000)	Doug Hacking ; Rosalind Smyth ; Nigel Shaw ; George Kokia ; Helen Carty ; David Heaf	Idiopathic pulmonary fibrosis in infants: good prognosis with conservative management
002575 (2000)	In ‘T Veen [Pays-Bas] ; Sterk [Pays-Bas] ; Bel [Pays-Bas]	Alternative strategies in the treatment of bronchial asthma
002624 (1999)	David A. Stempel	ALTERNATIVE ANTI-INFLAMMATORY AND IMMUNOMODULATOR MEDICATIONS FOR ASTHMA
002728 (1998)	P. Oxholm [Danemark] ; K. Asmussen [Danemark]	Standardized assessment of disease status in patients with primary Sjögren's syndrome: the foundation for creating criteria for disease activity and damage?
002731 (1998)	J. Müller-Quernheim [Allemagne]	Sarcoidosis: clinical manifestations, staging and therapy (part II)
002739 (1998)	Hilary C. Cain [États-Unis] ; Paul W. Noble [États-Unis] ; Richard A. Matthay [États-Unis]	PULMONARY MANIFESTATIONS OF SJGREN'S SYNDROME

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Lung function" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Lung function" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Lung function
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021